--- title: "Hengtong Logistics shareholder Jiang Shui plans to reduce holdings by no more than 1.21% of shares" type: "News" locale: "en" url: "https://longbridge.com/en/news/227220563.md" description: "According to the Zhitong Finance APP, Hengtong Logistics announced that shareholder Yu Jiangshui plans to reduce his holdings by no more than 8.6436 million shares within three months from the third trading day after the announcement, through a combination of centralized bidding and block trading, with a reduction ratio not exceeding 1.21% of the total shares of the company" datetime: "2025-02-05T13:16:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/227220563.md) - [en](https://longbridge.com/en/news/227220563.md) - [zh-HK](https://longbridge.com/zh-HK/news/227220563.md) generator: "portal-rs" --- # Hengtong Logistics shareholder Jiang Shui plans to reduce holdings by no more than 1.21% of shares According to the announcement from Zhitong Finance APP, Hengtong Logistics (603223.SH) announced that shareholder Yu Jiangshui plans to reduce his holdings by no more than 8.6436 million shares, accounting for no more than 1.21% of the total shares of the company, within three months starting from the third trading day after the announcement ### Related Stocks - [603223.CN](https://longbridge.com/en/quote/603223.CN.md) ## Related News & Research - [06:50 ETUnited Imaging secures CE mark for world's first dual wide-coverage CT family](https://longbridge.com/en/news/297901060.md) - [REG - Bytes Technology Grp - Holding(s) in Company](https://longbridge.com/en/news/297621542.md) - [China Merchants Energy Shipping: Net profit soared 227.6% on strong tanker rates and robust shipping demand](https://longbridge.com/en/news/297433471.md) - [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md) - [Cupid share price in focus on board approval to set up manufacturing venture in South African](https://longbridge.com/en/news/297455298.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**